Revisiting ovarian function suppression with GnRH agonists for premenopausal women with breast cancer: Who should use and the impact on survival outcomes

医学 肿瘤科 乳腺癌 内科学 妇科 癌症
作者
Linxiaoxi Ma,Benlong Yang,Jiong Wu
出处
期刊:Cancer Treatment Reviews [Elsevier BV]
卷期号:129: 102770-102770
标识
DOI:10.1016/j.ctrv.2024.102770
摘要

Breast cancer diagnosed in premenopausal women tends to be more aggressive and the benefit of ovarian function suppression (OFS), at least in certain groups of patients, is well known. There is hesitancy in using OFS in some groups of patients who may otherwise benefit from the treatment. For instance, it is clear that in premenopausal patients with hormone receptor-positive (HR + ), high-risk, early-stage breast cancer, gonadotropin-releasing hormone agonists (GnRHa) should be given in the adjuvant setting; however, confusion remains whether premenopausal patients with intermediate-risk disease benefit from GnRHa, given the lack of consensus on its definition in guidelines and clinical practice. Most recent evidence on the long-term efficacy of GnRHa, with up to 20-years of follow-up, reinforced its benefits in premenopausal patients with early-stage breast cancer. In this comprehensive review, we reviewed the long-term efficacy in terms of improvement in DFS and OS for early-stage HR + breast cancer and examined evidence from multiple randomized clinical studies to identify the clinicopathological characteristics that correlated with improved disease-free survival (DFS) and overall survival with the addition of OFS to adjuvant endocrine therapy. Other aspects of GnRHa, including its efficacy in advanced breast cancer, safety profile, evidence in ovarian function preservation, and the advantages of long-acting formulations were also discussed. By addressing the existing gaps and grey areas regarding the inclusion of OFS as a crucial treatment component for premenopausal breast cancer patients, physicians are more aware of who to administer and the potential impact on survival outcomes.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
赫江涛发布了新的文献求助10
刚刚
YQ发布了新的文献求助10
1秒前
余香的应助被高兴的若雁采纳,获得10
1秒前
无死何能生新颜完成签到,获得积分10
1秒前
1秒前
双小钧发布了新的文献求助10
2秒前
Emma完成签到,获得积分10
2秒前
Zyf123完成签到,获得积分10
2秒前
之星君完成签到,获得积分10
2秒前
匆匆发布了新的文献求助10
2秒前
2秒前
CScs25发布了新的文献求助10
2秒前
Berner完成签到,获得积分10
2秒前
杨坏完成签到,获得积分10
2秒前
3秒前
夏夏完成签到,获得积分10
3秒前
脑洞疼的应助被风雪征途采纳,获得10
3秒前
领导范儿的应助被复杂夜山采纳,获得10
4秒前
LuoYR@SZU完成签到,获得积分10
5秒前
搜集达人的应助被不安的雪萍采纳,获得30
5秒前
5秒前
5秒前
5秒前
zj发布了新的文献求助150
5秒前
我终于把李婷娶回家了完成签到,获得积分10
5秒前
FYY发布了新的文献求助10
7秒前
7秒前
8秒前
你好天空完成签到 ,获得积分20
9秒前
Ava的应助被BioRick采纳,获得10
9秒前
9秒前
9秒前
小竹子完成签到,获得积分10
9秒前
9秒前
脑洞疼的应助被anyway采纳,获得10
10秒前
Sylvia完成签到,获得积分10
10秒前
GUO发布了新的文献求助10
10秒前
Ov5完成签到,获得积分10
10秒前
夏侯乘风发布了新的文献求助10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192227
求助须知:如何正确求助?哪些是违规求助? 9578845
关于积分的说明 21862272
捐赠科研通 7791732
什么是DOI,文献DOI怎么找? 3436868
关于科研通互助平台的介绍 2560579
邀请新用户注册赠送积分活动 2483654